The potential role of interleukin-2 in patients with HIV infection.

Controlled Trial of Interleukin-2 Infusions in Patients Infected with the Human Immunodeficiency Virus

1996 • 406 citations

Immunologic and Virologic Effects of Subcutaneous Interleukin 2 in Combination With Antiretroviral Therapy

2000 • 179 citations

Comparison of subcutaneous and intravenous interleukin-2 in asymptomatic HIV-1 infection: a randomised controlled trial

1999 • 149 citations

Efficacy of Low‐Dose Subcutaneous Interleukin‐2 to Treat Advanced Human Immunodeficiency Virus Type 1 in Persons with ⩽250/μL CD4 T Cells and Undetectable Plasma Virus Load

1999 • 107 citations

Interleukin 2 Leads to Dose-Dependent Expression of the Alpha Chain of the IL-2 Receptor on CD25-Negative T Lymphocytes in the Absence of Exogenous Antigenic Stimulation

2000 • 44 citations

XIII International AIDS Conference

2000 • 42 citations

A randomized, controlled 24-week study of intermittent subcutaneous interleukin-2 in HIV-1 infected patients in Thailand

2000 • 40 citations

Concomitant Therapy With Subcutaneous Interleukin-2 and Zidovudine Plus Didanosine in Patients With Early Stage HIV Infection

1999 • 34 citations

Effects of Intermittent Interleukin‐2 Therapy on Plasma and Tissue Human Immunodeficiency Virus Levels and Quasi‐Species Expression

2000 • 30 citations

Comparison between subcutaneous and intravenous interleukin‐2 treatment in HIV disease

1998 • 24 citations

Immunotherapy of HIV-Infected Patients with Intermittent Interleukin-2: Effects of Cycle Frequency and Cycle Duration on Degree of CD4+ T-Lymphocyte Expansion

2001 • 20 citations

Short Communication: Methods of Using Interleukin 2 to Enhance HIV-Specific Immune Responses

2002 • 5 citations